Nitric oxide donors - current trends in therapeutic applications

Bibliography

• HOU YC, JANCZUK A, WANG PG: Current trends in the development, of nitric oxide donors. Curr. Pharm. Des. (1999) 5(6):417–441.
   PubMed Web of Science ®Google Scholar
• •Excellent review.
   Google Scholar
• STAMLER JS, FEELISCH M: NO donors. In: Biochemistry of Nitric, Oxide and Redox-related Species, Methods in Nitric Oxide Research. Stamler JS, Feelisch M (Eds.), John Wiley & Sons, New York (1996):19.
   Google Scholar
• ••Most systematic and comprehensive review.
   Google Scholar
• FURCHGOTT RF, ZAWADSKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylchloline. Nature (1980) 288:373–376.
   PubMed Web of Science ®Google Scholar
• IGNARRO LJ, BUGA GM, WOOD KS, BYRNS RE, CHAUDHURI G: Endothelium derived relaxing factor produced and released from arteries and veins is nitric oxide. Proc. Natl Acad. ScL USA (1987) 84:9265–9269.
   PubMed Web of Science ®Google Scholar
• PALMER RMJ, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 327:524–526.
   PubMed Web of Science ®Google Scholar
• MURAD F, MITTAL C, ARNOLD WP, KATSUKI S, KIMURA H: Guanylate cyclase: activation by azide, nitrocom-pounds, nitric oxide and hydroxyl radical and inhibi-tion by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. (1978) 9:145–158.
   PubMedGoogle Scholar
• CHEN J, WOLLMANN Y, CHERNICHOVSKY T, IAINA A, SOFER M, MATZKIN H: Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. (1999) 83 (3):269–273.
   PubMed Web of Science ®Google Scholar
• CORNFIELD DN, MARTIN EB, HAMPL V, ARCHER SL: Aerosol delivery of diethylenetriamin/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs. J. Lab. Clin. Med. (1999) 134(4):419–425.
   PubMed Web of Science ®Google Scholar
• TSUKAHARA H, ISHIDA T, MAYUMI M: Gas-phase oxidation of nitric oxide: chemical kinetics and rate constant. Nitric oxide: Biol. Chem. (1999) 3 (3):191–198.
   PubMed Web of Science ®Google Scholar
• IGNARRO LJ, FUKOTO JM, GRISCAVAGE JM, ROGERS NE, BYRNS RE: Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from t-arginine. Proc. Natl. Acad. Sci. USA (1993) 90(17):8103–8107.
   PubMed Web of Science ®Google Scholar
• DRAGO RS, PAULIK FE: The reaction of nitrogen(l)oxide with diethylamine. J. Amer. Chem. Soc. (1960) 82:96–98.
   Web of Science ®Google Scholar
• KEEFER LK, NIMS RW, DAVIES KM, WINK DA: NONOates(1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosages forms. Methods Enzymol. (1996) 268(27): 281–293.
   PubMedGoogle Scholar
• •Informative article.
   Google Scholar
• WIRTZ P, MENZEL L, BLOCH W, HEB A, MICHEL O, URBAN W: LMR spectroscopy, a new sensitive method for on-line recording of nitric oxide in breath. J. Appl. Physiology (1999) 86:1075–1080.
   PubMed Web of Science ®Google Scholar
• •New method in NO analysis.
   Google Scholar
• HORSTMANN A, MENZEL L, URBAN W, LEHMANN J: Release of Nitric oxide from Diazeniumdiolates monitored by Laser Magnetic Resonance Spectros-copy. In: First International Conference, Biology, Chemistry and Therapeutic Applications of Nitric Oxide. San Francisco, USA (2000).
   Google Scholar
• HRABIE JA, KLOSE JR, WINK DA, KEEFER LK: New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. (1993) 58:1472–1476.
   Web of Science ®Google Scholar
• ••Report on the most important class of diazeniumdiolates.
   Google Scholar
• SUSCHEK CV, KRISCHEL V, BRUCH-GERHARZ D et al.:Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bc1-2-regulation. J. Biol. Chem. (1999) 274(106130–6137.
   Web of Science ®Google Scholar
• FERNANDEZ-TOME P, LIZASOAIN I, LEZA JC, LORENZO P,MORO MA: Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones. Neuropharmacology (1999) 38(9):1307–1315.
   PubMed Web of Science ®Google Scholar
• CHAMPION HC, BIVALACQUA TJ, WANG R et al Induction, of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors, in the cat. J. Urol (1999) 161 (6) 2013–2019
   PubMed Web of Science ®Google Scholar
• FABISIAK JP, TYURIN VA, TYURINA YY, SEDLOV A, LAZOJS, KAGAN VE: Nitric oxide dissociates lipid oxidation from apoptosis and phosphatidylserine externaliza-tion during oxidative stress. Biochemistry (2000) 39(1):127–138.
   PubMed Web of Science ®Google Scholar
• JACOBS BR, BRILLI RJ, BALLARD ET, PASSERINI DJ, SMITHDJ: Aerolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am. J. Respir. Crit. Care Med. (1998) 158:1536–1542.
   PubMed Web of Science ®Google Scholar
• •Important perspectives in treatment of pulmonary diseases.
   Google Scholar
• CORNFIELD DN, MARTIN EB, HAMPL V, ARCHER SL: Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs. J. Lab. Clin. Med. (1999) 134(0419–425.
   PubMed Web of Science ®Google Scholar
• SAAVEDRA JE, BILLIAR TR, WILLIAMS DL, KIM Y-M, WATKINS SC, KEEFER LK: Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-a-induced apoptosis and toxicity in the liver. J. Med. Chem. (1997) 40:1947–1954.
   Google Scholar
• ••Innovative NO donor prodrugs.
   Google Scholar
• DUCHSTEIN H-J, REIDERER S, ERBACH C:Aktive stickstoffspezies, - em n neues forschungsgebiet fur die pharmazeutische chemie. Pharm. Unserer Z. (1999) 28:197–207.
   PubMedGoogle Scholar
• SAAVEDRA JE, SHAMI PJ, WANG LY et al Esterase- sensitive, nitric oxide donors of the diazeniumdiolate family,: In vitro antileukemic activity. J. Med. Chem. (2000) 43:261–269.
   PubMed Web of Science ®Google Scholar
• STAMMLER JS, SIMON DI, OSBORNE JA et al.: S,-Nitrosylation of proteins with nitric oxide; synthesis and characerization of biologically active compounds. Proc. Natl. Acad. Sci. USA (1992) 89:444–448.
   PubMed Web of Science ®Google Scholar
• •The role of endogenous S-nitrosothiols.
   Google Scholar
• PATEL HMS, WILLIAMS DLH: Nitrosation by alkyl nitrites, part 6. Thiolate nitrosation. In: J. Chem. Soc. Perkin Trans. 2 (199037–42.
   Google Scholar
• JIA L, BONAVENTURA C, BONAVENTURA J, STAMLER JS: S-nitroso-haemoglobin: a dynamic activity of blood involved in vascular control. Nature (1996) 389:221–226.
   Google Scholar
• ••New knowledge on the regulation of blood pressure andoxygen transport. KOSAKA, H: Nitric oxide and hemoglobin interaction in the vasculature. Biochim. Biophys. Acta (1999) 1411:370–377.
   Google Scholar
• PERICHINI T, COLASANTI M, LAURO GM, ASCENZI P: Cysteine nitrosylation inactivates the 11IV-1 protease. Biochem. Biophys. Res. Commun. (1998) 250:575–576.
   PubMed Web of Science ®Google Scholar
• CASTRO C, RUIZ FA, PEREZ-MATO I et al.: Creation of a functional S-nitrosylation site in vitro by single point mutation. FEBS Lett. (1999) 459:319–322.
   PubMed Web of Science ®Google Scholar
• KHAN F, GREIG IR, NEWTON DJ, BUTLER AR, BELCH JJF: The effect of exogenous nitric oxide on thermal blood flow. The Lancet (1997) 350:410–411.
   PubMed Web of Science ®Google Scholar
• MEGSON IL, MORTON S, GREIG IR et al.: N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries. Br. J. Pharmacol. (1999) 126:639–648.
   PubMed Web of Science ®Google Scholar
• JIA L, YOUNG X, GUO W: Physicochemistry, pharma-cokinetics and pharmacodynamics of S- nitrosocapto-pril crystals, a new nitric oxide donor. J. Pharm. ScL (1999) 88:981–986.
   PubMed Web of Science ®Google Scholar
• AHLNER J, ANDERSSON RGG, TORFGARD K., AXELSON KL: Organic nitrate esters: clinical use and mechanisms of action. Pharmacol. Rev. (1991) 43:351–423.
   Google Scholar
• ••Excellent and very comprehensive review.
   Google Scholar
• HASEGAWA K, TANIGUCHI T, TAKAKURA K, GOTO Y, MURAMATSU I: Possible involvement of nitroglycerin converting step in nitroglycerin tolerance. Life ScL (1999) 64:2199–2206.
   PubMed Web of Science ®Google Scholar
• HINZ B, SCHROEDER H: Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis. Biochem. Biophys. Res. Commun. (1998) 252:232–235.
   PubMed Web of Science ®Google Scholar
• FINK B, BASSENGE E: Unexpected, tolerance-devoid vasomotor and platelet actions of penterythrityl tetranitrate. j Cardiovasc. Pharmacol (1997) 30:831–835.
   PubMed Web of Science ®Google Scholar
• ••A nitrate without nitrate tolerance.
   Google Scholar
• DE MEY C: Opportunities for the treatment of erectile dysfunction, by modulation of the NO axis - alterna-tives to sildenafil citrate. Curr. Med. Res. Opin. (1998) 14:187–202.
   PubMed Web of Science ®Google Scholar
• NAKATSDUKA M, TADA K, KIMURA Y et al.: Clinical experience of long-term trandermal treatment with nitric oxide donor for women with preeclampsia. Gynacol. ObsteL Invest. (1999) 47:13–19.
   PubMed Web of Science ®Google Scholar
• TANDER B, GUVEN A, DEMIRBAG S et al.: A prospective, randomized, double-blind, placebo-controlled trial of glyceryl-trinitrate ointment in the treatment of children with anal fissure. J. Pediatr. Surg. (1999) 34:1810–1812.
   PubMed Web of Science ®Google Scholar
• •New application for GTN studied with humans.
   Google Scholar
• OLIVER DW, DORMEHL IC: Cerebral blood flow effects of the nitric oxide donor nitroglycerin and its drug combinations in the non-human primate model. Arzneimittelforschung (1999) 49:732–739.
   PubMed Web of Science ®Google Scholar
• FIORUCCI S, ANTONELLI W, SANTUCCI L et al.: Gastroin-testinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 116:1089–1106.
   PubMed Web of Science ®Google Scholar
• DAVIES NM, ROSETH AG, APPLEYARD CB et al.: NO-naproxen vs. naproxen: ulcerogenic, analgesic and antiinflammatory effects. Aliment. Pharmacol. Ther. (1997) 11:69–79.
   Google Scholar
• ENDRES S, HACKER A, NOACK E, KOJDA G, LEHMANN J: NO-donors, part 3: nitrooxyacylated thiosalicylates and salicylates - synthesis and biological activities. Eur. J. Med. Chem. (1999) 34:895–901.
   PubMed Web of Science ®Google Scholar
• OGAWA T, NAKAZATO A, TSCHICHIDA K, HATAYAMA K:Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position. Chem. Pharm. Bull. (1993) 41:108–116.
   PubMed Web of Science ®Google Scholar
• WESSLER C, DIEWALD D, LEHMANN J: Synthesis of nitrooxylated 4-phenyl-1,4-dihydropyridines as potential vasonetural calcium channel activators. Fourth European Congress of Pharmaceutical Sciences, Milan (1998). Eur.J. Pharm. ScL (1998) 6\(Suppl. 1):37.
   Google Scholar
• SCHONAFINGER K: Heterocyclic NO prodrugs. Farmaco(1999) 54:316–320.
   PubMedGoogle Scholar
• REHSE K, SHAHROURI T: New NO donors with antithrombotic and vasodilating activities, part 24. Hydrazone derivatives. Arch. Pharm. Med. Chem. (1998) 331:308–312.
   PubMedGoogle Scholar